Clinical Trial Update: Combined Simvastatin and Irinotecan in Treating ES-SCLC Patients Relapsed From 1st Chemotherapy [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the combination of simvastatin and irinotecan in extensive-stage small cell lung cancer patients who relapsed after first-line chemot…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Simvastatin + Irinotecan

Snippet

Sponsor: Shanghai Pulmonary Hospital, Shanghai, China | Conditions: Small Cell Lung Cancer | Phase 2 | Status: UNKNOWN